Hangzhou Biotest Biotech Co Ltd (688767) — Cash Flow Reinvestment Rate
Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Reinvestment Rate of 1.66x as of September 2025, reinvesting CN¥47.02 Million (capex CN¥47.02 Million ) from operating cash flow of CN¥28.39 Million. Explore 688767 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Biotest Biotech Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Also explore how large is Hangzhou Biotest Biotech Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Hangzhou Biotest Biotech Co Ltd. For live market cap and broader valuation context, see Hangzhou Biotest Biotech Co Ltd (688767) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.65x | CN¥388.70 Million | CN¥106.47 Million | CN¥129.87 Million | ▼ -43.9% |
| 2024 | 6.51x | CN¥838.33 Million | CN¥128.83 Million | CN¥245.05 Million | ▲ +553.7% |
| 2023 | 1.00x | CN¥130.79 Million | CN¥131.38 Million | CN¥56.42 Million | ▲ +154.0% |
| 2022 | 0.39x | CN¥275.63 Million | CN¥703.21 Million | CN¥178.92 Million | ▼ -55.5% |
| 2021 | 0.88x | CN¥800.17 Million | CN¥908.12 Million | CN¥200.20 Million | ▲ +245.5% |
| 2020 | 0.26x | CN¥113.76 Million | CN¥446.07 Million | CN¥57.68 Million | ▼ -91.7% |
| 2019 | 3.08x | CN¥78.94 Million | CN¥25.67 Million | CN¥39.47 Million | ▲ +414.0% |
| 2018 | 0.60x | CN¥12.67 Million | CN¥21.17 Million | CN¥12.67 Million | ▼ -83.9% |
| 2017 | 3.73x | CN¥26.37 Million | CN¥7.07 Million | CN¥26.37 Million | — |